UnitedHealth Group Inc. (UNH) — Quantitative Forecast & Factor Scores

UNH currently carries a valuation grade of Strong Buy. The trailing P/E of 21.5 is roughly in line with the Healthcare sector median of 22.0x. Our discounted cash flow model suggests an intrinsic range of $301–$552, implying a +50% margin of safety at the current price of $284.33.

With a beta of 0.38, UNH exhibits a low-volatility risk profile relative to the broad market. Net margins of 2.7% fall below the Healthcare average of 18%, suggesting potential margin pressure. Return on equity stands at 12.5%. The balance sheet is conservatively leveraged at 82% debt-to-equity.

The company has beaten estimates in 67% of recent quarters, a moderate hit rate. The most recent quarter delivered a +188.0% earnings surprise. Analyst estimate revisions are trending accelerating.

Insider transactions show net buying of $36,770,322 over the trailing period, a signal often associated with management confidence. Short interest is low at 1.6% of float, suggesting limited bearish conviction.

At 0.49, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 38.6% exceeds realized volatility of 27.5% by 11 points, suggesting options are pricing in elevated risk.

As a Healthcare constituent, UNH's risk profile should be evaluated alongside sector peers when constructing diversified portfolios.